Mucoadhesive and muco-penetrating delivery systems for eradication of Helicobacter pylori

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Asian Journal of Pharmaceutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.22377/AJP.V6I1.69
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin.

  2011cited by this paper
• Stomach-Specific Controlled Release Gellan Beads of Acid-Soluble Drug Prepared by Ionotropic Gelation Method

  2010cited by this paper
• Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.

  2010cited by this paper
• Helicobacter pylori infection and current clinical areas of contention

  2010cited by this paper
• Floating tablets of Famotidine with natural polymer: An approach for gastric treatment K.Gnanaprakash, K.B.Chandhra Shekhar and C.Madhu

  2010cited by this paper
• Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

  2009cited by this paper
• The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.

  2009cited by this paper
• Helicobacter pylori in health and disease.

  2009cited by this paper
• Glycosylated liposomes against Helicobacter pylori: behavior in acidic conditions.

  2009cited by this paper
• Fabrication and evaluation of levofloxacin hemihydrate floating tablet

  2009cited by this paper
• Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori

  2009influential reference
• Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.

  2009cited by this paper
• Helicobacter pylori moves through mucus by reducing mucin viscoelasticity

  2009cited by this paper
• Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

  2009cited by this paper
• Drug resistance pattern and clonality in H. pylori strains.

  2009cited by this paper
• Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection.

  2009cited by this paper
• Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy

  2009cited by this paper
• Can Helicobacter pylori Invade Human Gastric Mucosa?: An In Vivo Study Using Electron Microscopy, Immunohistochemical Methods, and Real-time Polymerase Chain Reaction

  2009cited by this paper
• Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis.

  2008cited by this paper
• Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori

  2008cited by this paper
• Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori

  2008cited by this paper
• Formulation and Evaluation of Gastroretentive Dosage Forms of Clarithromycin

  2008cited by this paper
• Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.

  2008cited by this paper
• Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations.

  2008cited by this paper
• Polymers for mucoadhesive drug delivery system: a current status.

  2008cited by this paper
• Prevalence of Helicobacter pylori in asymptomatic subjects--a nested PCR based study.

  2008cited by this paper
• Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori.

  2008cited by this paper
• Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.

  2007cited by this paper
• Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy.

  2007cited by this paper
• Apoptosis in different gastric lesions and gastric cancer: relationship with Helicobacter pylori, overexpression of p53 and aneuploidy.

  2007cited by this paper
• Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.

  2007cited by this paper
• Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.

  2007cited by this paper
• Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori

  2007cited by this paper
• Duodenal Ulcer Promoting Gene of Helicobacter pylori

  2006cited by this paper
• Emulsion gel beads of calcium pectinate capable of floating on the gastric fluid: effect of some additives, hardening agent or coating on release behavior of metronidazole.

  2005cited by this paper
• In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin.

  2005cited by this paper
• High relative content of lysophospholipids of Helicobacter pylori mediates increased risk for ulcer disease.

  2005cited by this paper
• Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus

  2004cited by this paper
• Correlation between Helicobacter pylori OipA Protein Expression and oipA Gene Switch Status

  2004cited by this paper
• Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori.

  2004influential reference
• H pylori antibiotic resistance: prevalence, importance, and advances in testing

  2004cited by this paper
• Helicobacter pylori persistence: biology and disease.

  2004cited by this paper
• Receptor Mediated Targeting of Lectin Conjugated Gliadin Nanoparticles in the Treatment of Helicobacter pylori

  2003cited by this paper
• Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection

  2003cited by this paper
• Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori

  2003cited by this paper
• Kinetic studies of the degradation of an aminopenicillin antibiotic (amoxicillin trihydrate) in aqueous solution using heat conduction microcalorimetry

  2003cited by this paper
• Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin.

  2002cited by this paper
• Helicobacter pylori SabA Adhesin in Persistent Infection and Chronic Inflammation

  2002cited by this paper
• Floating microparticles based on low density foam powder.

  2002cited by this paper
• The Helicobacter pylori Blood Group Antigen-Binding Adhesin Facilitates Bacterial Colonization and Augments a Nonspecific Immune Response1

  2002cited by this paper
• Floating-Bioadhesive Microspheres Containing Acetohydroxamic Acid for Clearance of Helicobacter Pylori

  2002cited by this paper
• Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin.

  2001cited by this paper
• Chitosan and its derivatives in mucosal drug and vaccine delivery.

  2001cited by this paper
• Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.

  2001cited by this paper
• Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals.

  2000cited by this paper
• Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori.

  2000cited by this paper
• Agglutination of Helicobacter pylori coccoids by lectins.

  2000cited by this paper
• Regional Differences in Metronidazole Resistance and Increasing Clarithromycin Resistance among Helicobacter pylori Isolates from Japan

  2000cited by this paper
• Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.

  2000influential reference
• Recombination and clonal groupings within Helicobacter pylori from different geographical regions

  1999cited by this paper
• The relationship between Helicobacter pylori motility, morphology and phase of growth: implications for gastric colonization and pathology.

  1999cited by this paper
• Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder.

  1999cited by this paper
• Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration

  1999cited by this paper
• Determination of amoxicillin in human serum and plasma by high-performance liquid chromatography and on-line postcolumn derivatisation.

  1998cited by this paper
• Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging.

  1998cited by this paper
• Free recombination within Helicobacter pylori.

  1998cited by this paper
• The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.

  1997cited by this paper
• Cost-effectiveness of Helicobacter pylori eradication in India: to live and let live ... expensively?

  1997cited by this paper
• Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection

  1997influential reference
• Gastric mucus of the guinea pig: proton carrier and diffusion barrier.

  1997cited by this paper
• In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions

  1996cited by this paper
• Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.

  1995cited by this paper
• Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori

  1994cited by this paper
• Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy.

  1994cited by this paper
• Targeting of drugs and vaccines to the gut.

  1994cited by this paper
• Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

  1993cited by this paper
• LocalGastric andSerumAmoxicillin Concentrations after Different OralApplication Forms

  1993cited by this paper
• A surface energy analysis of mucoadhesion II. Prediction of mucoadhesive performance by spreading coefficients

  1993cited by this paper
• Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori.

  1992cited by this paper
• Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects.

  1991cited by this paper
• Bioadhesive Polymers - Synthesis, Evaluation and Application in Controlled Release Tablets

  1991cited by this paper
• Helicobacter pylori infection and the risk of gastric carcinoma.

  1991cited by this paper
• Lectin Typing of Helicobacter pylori

  1990influential reference
• Campylobacter pylori and peptic ulcer disease.

  1989cited by this paper
• Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

  1989cited by this paper
• Strain characterization and grouping of Campylobacter jejuni and Campylobacter coli by interaction with lectins

  1986influential reference
• UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS

  1983cited by this paper
• Sci Pharm www.scipharm.at Research article Open Access Amoxicillin Loaded Chitosan–Alginate Polyelectrolyte Complex Nanoparticles as

  year unknowncited by this paper

• AQUASOMES UNVEILED: TRANSFORMING DRUG DELIVERY WITH CUTTING-EDGE THERAPEUTIC CARRIERS AND RECENT BREAKTHROUGHS

  2024cites this paper
• Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection

  2024cites this paper
• Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation

  2023cites this paper
• Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal against Helicobacter pylori

  2023cites this paper
• Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori Infection.

  2023cites this paper
• Design and Synthesis of Multifunctional Polymeric Micelles for Targeted Delivery in Helicobacter pylori Infection

  2022cites this paper
• The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications

  2022cites this paper
• Polymeric drug carriers against Helicobacter pylori

  2021cites this paper
• Design of enzyme decorated mucopermeating nanocarriers for eradication of H. pylori infection

  2020cites this paper
• In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels

  2019cites this paper
• Optimization and in vivo evaluation of duloxetine hydrochloride buccoadhesive lyophilized tablets

  2019cites this paper
• Sustainable Agriculture Reviews 36: Chitin and Chitosan: Applications in Food, Agriculture, Pharmacy, Medicine and Wastewater Treatment

  2019cites this paper
• Application of Chitosan-Based Formulations in Controlled Drug Delivery

  2019cites this paper
• Formulasi dan Evaluasi Hidrogel Mukoadhesif Metronidazol Menggunakan Kombinasi Kitosan dan Natrium Karboksimetilselulosa Menggunakan Desain Faktorial

  2019cites this paper
• An overview of nanotechnology-based treatment approaches against Helicobacter Pylori

  2019cites this paper
• FORMULATION AND IN-VITRO EVALUATION OF METRONIDAZOLE LOADED HPMC K15M MUCOADHESIVE MICROCAPSULES FOR H. PYLORI INFECTION USING 3

  2019cites this paper
• Famotidine microspheres reconstituted with floating in situ gel for stomach-specific delivery: Preparation and characterization

  2017cites this paper
• Formulation and advantages of furazolidone in liposomal drug delivery systems.

  2016cites this paper
• Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori.

  2015cites this paper
• Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin

  2015cites this paper
• Modification of drug delivery to improve antibiotic targeting to the stomach.

  2015cites this paper
• The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection

  2014cites this paper